Kenshiro Takemoto

Hiroshima, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 55 publications

RIOK2 Promotes Clear Cell Renal Cell Carcinoma Progression Through Cell Cycle Regulation.

RIOK2 Promotes Clear Cell Renal Cell Carcinoma Progression Through Cell Cycle Regulation.

Journal: Cancer medicine

Published: June 19, 2026

Clinical and genomic characteristics of primary resistant disease to first-line immuno-oncology plus VEGFR inhibitor therapy in metastatic renal cell carcinoma.

Clinical and genomic characteristics of primary resistant disease to first-line immuno-oncology plus VEGFR inhibitor therapy in metastatic renal cell carcinoma.

Journal: Scientific reports

Published: March 31, 2026

External Validation of Prognostic Models for Nonmetastatic Clear Cell Renal Cell Carcinoma in a Japanese Cohort: Evaluation of Predictive Performance.

External Validation of Prognostic Models for Nonmetastatic Clear Cell Renal Cell Carcinoma in a Japanese Cohort: Evaluation of Predictive Performance.

Journal: International journal of urology : official journal of the Japanese Urological Association

Published: March 04, 2026

Urine culture-guided antibiotic prophylaxis reduces febrile pyelonephritis after ureteral stent removal following radical cystectomy.

Urine culture-guided antibiotic prophylaxis reduces febrile pyelonephritis after ureteral stent removal following radical cystectomy.

Journal: World journal of urology

Published: January 09, 2026

Over-expression of Paternally Expressed Gene 10 (PEG10) Is Associated With Poor Prognosis in Upper Tract Urothelial Carcinomas.

Over-expression of Paternally Expressed Gene 10 (PEG10) Is Associated With Poor Prognosis in Upper Tract Urothelial Carcinomas.

Journal: Anticancer research

Published: December 21, 2025

Genomic and Clinical Impact of Smoking on Therapeutic Outcomes in Prostate Cancer: A Public Databases Analysis.

Genomic and Clinical Impact of Smoking on Therapeutic Outcomes in Prostate Cancer: A Public Databases Analysis.

Journal: The Prostate

Published: September 18, 2025

KIFC1 is Associated With Sarcomatoid Differentiation, Immune Response, and a Poor Prognosis in Clear Cell Renal Cell Carcinoma.

KIFC1 is Associated With Sarcomatoid Differentiation, Immune Response, and a Poor Prognosis in Clear Cell Renal Cell Carcinoma.

Journal: Cancer medicine

Published: August 09, 2025

Comprehensive Analysis of Tumor Mutational Burden in Prostate Cancer: Multipublic Dataset Analysis.

Comprehensive Analysis of Tumor Mutational Burden in Prostate Cancer: Multipublic Dataset Analysis.

Journal: Clinical genitourinary cancer

Published: August 07, 2025

Crucial Contribution of BACH1 to Bladder Cancer Progression via Upregulating Epithelial-Mesenchymal Transition Pathway.

Crucial Contribution of BACH1 to Bladder Cancer Progression via Upregulating Epithelial-Mesenchymal Transition Pathway.

Journal: Cancer science

Published: August 01, 2025

Comprehensive Analysis of Fraction of Genome Altered in Prostate Cancer Treatment.

Comprehensive Analysis of Fraction of Genome Altered in Prostate Cancer Treatment.

Journal: The Prostate

Published: July 12, 2025

Angiotensin II type 1 receptor signaling promotes bladder cancer progression and its inhibition by Losartan.

Angiotensin II type 1 receptor signaling promotes bladder cancer progression and its inhibition by Losartan.

Journal: Hypertension research : official journal of the Japanese Society of Hypertension

Published: July 04, 2025

Efficacy of Open-Ended Urinary Catheters in Preventing Catheter-Related Bladder Discomfort: A Randomized Controlled Trial.

Efficacy of Open-Ended Urinary Catheters in Preventing Catheter-Related Bladder Discomfort: A Randomized Controlled Trial.

Journal: International journal of urology : official journal of the Japanese Urological Association

Published: July 01, 2025

Showing 1-12 of 55

Last Updated: 09/26/2026